Comparison

GenCrispr NLS-Cas9-EGFP Nuclease European Partner

Item no. Z03393-50
Manufacturer GenScript
Amount 50 ug (1mg/ml)
Category
Type Proteins
Specific against other
Dry ice Yes
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Available
Description
GenCrispr NLS-Cas9-EGFP is a fusion protein developed by GenScript. It contains a nuclear localization sequence (NLS) on its N terminal and EGFP on the C terminal. Cas9 nuclease is an RNA-guided endonuclease that can catalyze cleavage of double stranded DNA. This kind of targeted nuclease is a powerful tool for genome editing with high precision. Cas9 protein forms a very stable ribonucleoprotein (RNP) complex with the guide RNA (gRNA) component of the CRISPR/Cas9 system. The Cas9 RNP complex can localize to the nucleus immediately upon entering the cell with the addition of a nuclear localization signal (NLS). There is no requirement for transcription or translation compared with mRNA or plasmid systems. Additionally, the Cas9 RNP complex is rapidly cleared from the cells minimizing the chance of off-target cleavage when compared to other systems (Kim, et al. 2014). The EGFP can be taken as a reporter for tracking or sorting transfected cells, which creates the possibility of enriching cell populations for desired genome edits via fluorescence activated cell sorting (FACS). It significantly reduces the labor and cost associated with single cell cloning and genotyping in genome editing applications. Product Source: GenCrispr NLS-Cas9-EGFP is produced by expression from an E. coli strain.KEY FEATURES . DNA-free: no external DNA added to system. High cleavage efficiency: NLS ensures the efficient entry of Cas9 protein into nuclei. Low off target: transient expression of Cas9 nuclease. Time-saving: no need for transcription and translation. Reduced-labor: enrich cell populations for desired genome edits via EGFP-based fluorescence activated cell sorting (FACS). . Utilities of Product . Screening for highly efficient and specific targeting gRNAs by in vitro DNA cleavage. In vivo gene editing when combined with a specific gRNA by electroporation or injection. Enrich cell populations for desired genome edits via EGFP-based fluorescence activated cell sorting (FACS). .
Shipping Temperature
4C
Storage Temperature
-20C
Manufacturers Category
Molecular Biology
Manufacturers Product Line
Genome Editing
Product Origin
USA

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 ug (1mg/ml)
Available: In stock
available

Delivery expected until 12/13/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close